Literature DB >> 1233265

Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.

E Kaldestad, T Hansen, H K Brath.   

Abstract

A clinical-pharmacological study was performed to determine the effect of acetylsalicylic acid upon the serum concentration of indomethacin. 14 rheumatic patients were given indomethacin orally (25 mg X 4 for 4 days) and concurrently acetylsalicylic acid 3.7 g orally (0.9 g X 3 and 1.0 g X 1 daily), and 21 rheumatic patients were given indomethacin rectally in the morning (100 mg X 1) and concurrently acetylsalicylic acid 3.7 g orally (0.9 g X 3 and 1.0 g X 1 daily). On comparison with treatment with oral or rectal indomethacin alone, it was found that peak serum concentrations of indomethacin were significantly reduced (1% level), the times of the peaks were not shifted, and the areas beneath the serum concentration curves of indomethacin were smaller, but significantly so only if compared with rectal administration. In 12 rheumatic patients given indomethacin by rectum in the evening (100 mg X 1) and concurrently acetylsalicylic acid 3.7 g (0.9 g X 3 and 1.0 g X 1 daily), the serum level of indomethacin on the following morning (after 11 h) did not differ from that found after rectal treatment. A statistically but not biologically significant difference was observed between the mean serum half-lives of indomethacin given orally and rectally. For unknown reasons, concurrent doses of acetylsalicylic acid and indomethacin made the mean serum half-life of indomethacin longer than after its oral administration, but shorter than when the same dose of indomethacin was given rectally. There was no difference between serum levels of salicylate after oral administration of acetylsalicylic acid alone or after a concurrent oral or rectal dose of indomethacin. The results have been related to those reported previously, with respect to the interaction between indomethacin and acetylsalicylic acid, the serum levels of indomethacin after oral and rectal dosing, and the serum half-life of indomethacin based upon a one- or two-compartment model. The clinical relevance of the study is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233265     DOI: 10.1007/bf00614018

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  INDOMETHACIN: STUDIES OF ABSORPTION AND OF THE USE OF INDOMETHACIN SUPPOSITORIES.

Authors:  L P HOLT; C F HAWKINS
Journal:  Br Med J       Date:  1965-05-22

2.  Effect of concurrent administration of aspirin and indomethacin on serum concentrations.

Authors:  B Lindquist; K M Jensen; H Johansson; T Hansen
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

3.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

4.  The effect of aspirin on serum indomethacin.

Authors:  G D Champion; H E Paulus; E Mongan; R Okun; C M Pearson
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

Review 5.  Indomethacin: a survey of clinical trials.

Authors:  W M O'Brien
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

6.  Indomethacin: plasma concentrations and protein binding in man.

Authors:  E Hvidberg; H H Lausen; J A Jansen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

7.  Salicylate accumulation kinetics in man.

Authors:  G Levy; T Tsuchiya
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

8.  Interaction between aspirin and indomethacin in the treatment of rheumatoid arthritis.

Authors:  R Jeremy; J Towson
Journal:  Med J Aust       Date:  1970-07-18       Impact factor: 7.738

9.  A three-month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  1967 Jan-Feb       Impact factor: 6.875

10.  Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats.

Authors:  D W Yesair; L Remington; M Callahan; C J Kensler
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

View more
  4 in total

Review 1.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

2.  Comparative pharmacology of a 1:10 combination of indomethacin-sodium salicylate.

Authors:  E Ezer; E Pálosi; G Hajós; B Rosdy; L Szporny
Journal:  Agents Actions       Date:  1979-04

3.  Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.

Authors:  K C Kwan; G O Breault; R L Davis; B W Lei; A W Czerwinski; G H Besselaar; D E Duggan
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

4.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.